Patel Samir Rashmikant 13D/13G Filings for Akari Therapeutics, Plc (AKTX)

Patel Samir Rashmikant 13D and 13G filings for Akari Therapeutics, Plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-14
4:05 pm
Purchase		 2022-12-31 13G Akari Therapeutics, Plc
AKTX		 Patel Samir Rashmikant 19,655
9.900%		 10,460increase
(+113.75%)		 Filing
2022-02-14
08:02 am
Purchase		 2021-12-31 13G Akari Therapeutics, Plc
AKTX		 Patel Samir Rashmikant 9,195
6.200%		 2,964increase
(+47.57%)		 Filing
2021-02-16
08:31 am
Purchase		 2020-12-31 13G Akari Therapeutics, Plc
AKTX		 Patel Samir Rashmikant 6,231
7.200%		 2,421increase
(+63.54%)		 Filing